|Articles|November 1, 2013
- BioPharm International-11-01-2013
- Volume 26
- Issue 11
BioPharm International, November 2013 Issue (PDF)
Click the title above to open the BioPharm International November 2013 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 12 years ago
Supplier-Change Management for Drug-Product Manufacturersover 12 years ago
Report from Brazilover 12 years ago
Risk Aversion and Closed-System Processingover 12 years ago
The State of the Used-Equipment Marketover 12 years ago
Challenges in Managing the Cold Chainover 12 years ago
European Union Introduces GMPs for Excipientsover 12 years ago
USP Plans Standards on Good Distribution Practicesover 12 years ago
New Funding and Approval Pathways Prove PopularNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
5
